OVELMFRI
Live / Applied — Fourth extension granted (statement of use) (as of 02 May 2025)
What this means for you
Not registered yet, but its 27 Apr 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97384305
- Mark type
- Stylized text
- Filed
- 27 Apr 2022
- Published for opposition
- 21 Mar 2023
- Attorney of record
- Virginia Wolk Marino
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of depressive and anxiety disorders
Owner
- Breckenridge Pharmaceutical, Inc., Berkeley Heights, NJ, US
- Breckenridge Pharmaceutical, Inc., Berlin, CT, US
Prosecution history
- 13 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 03 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 May 2025 — SOU EXTENSION 4 GRANTED
- 02 May 2025 — SOU EXTENSION 4 FILED
- 02 May 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Sept 2024 — SOU EXTENSION 3 GRANTED
- 17 Sept 2024 — SOU EXTENSION 3 FILED
- 17 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 08 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 May 2024 — SOU EXTENSION 2 GRANTED
- 07 May 2024 — SOU EXTENSION 2 FILED
- 07 May 2024 — SOU TEAS EXTENSION RECEIVED
- 18 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Nov 2023 — SOU EXTENSION 1 GRANTED